A 2-day meeting highlighted the risk for a rare lymphoma, described as a ‘man-made cancer,’ and heard calls for a ban on certain products, but advisers also highlighted lack of data.
Medscape Medical News
A 2-day meeting highlighted the risk for a rare lymphoma, described as a ‘man-made cancer,’ and heard calls for a ban on certain products, but advisers also highlighted lack of data.
Medscape Medical News
